Showing results (271-280 of 289) with videos related to
Sort By:
Pageof 29
Cancer Letters|October 24, 2022
IFNγ-IL-17+ CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinomaYun Hua Lee, Samuel Chuah, Phuong H D Nguyen, et al.Liver Cancer|April 21, 2025
The Impact of Radiation Dose and Tumour Burden on Outcomes in Hepatocellular Carcinoma: 11-Year Experience in a 413-Patient Cohort Treated with Yttrium-90 Resin Microsphere RadioembolisationKaina Chen, Aaron K T Tong, Fiona N N Moe, et al.Journal of Hepatocellular Carcinoma|August 24, 2022
Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging SystemIan J Y Wee, Fiona N N Moe, Rehena Sultana, et al.Neuro-Oncology Advances|April 21, 2026
Outcomes of H3K27M-altered diffuse midline glioma adult Chinese patients and real-world experience with German-sourced ONC201 targeted therapy: A multi-center study in Hong KongPeter Y M Woo, Clara K W Lee, Lai-Fung Li, et al.The Lancet. Gastroenterology & Hepatology|October 25, 2021
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trialDavid Tai, Kelvin Loke, Apoorva Gogna, et al.World Journal of Surgery|March 7, 2013
Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trialA Y F Chung, L L P J Ooi, D Machin, et al.Nature Communications|January 12, 2021
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinomaPhuong H D Nguyen, Siming Ma, Cheryl Z J Phua, et al.Hepatology Communications|August 21, 2024
GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinomaN Jannah M Nasir, Samuel Chuah, Timothy Shuen, et al.Annals of Surgery|June 27, 2017
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International CohortJian Zheng, Joanne F Chou, Mithat Gönen, et al.Hepatology (Baltimore, Md.)|February 20, 2022
Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCCSheena Suthen, Chun Jye Lim, Phuong H D Nguyen, et al.Pageof 29